Edward G. Shaw

Q: What Schools Are Affiliated With Edward G. Shaw

Edward G. Shaw is affiliated with the following schools: University of California, Irvine, MD Anderson Cancer Center, Wake Forest University, Johns Hopkins University

Edward G. Shaw's AcademicInfluence.com Rankings

Edward G. Shaw

Philosophy

#9560

World Rank

#13140

Historical Rank

Logic

#6533

World Rank

#8057

Historical Rank

philosophy Degrees

Edward G. Shaw

Biology

#13160

World Rank

#16690

Historical Rank

Neuroscience

#2265

World Rank

#2326

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Edward G. Shaw's Degrees

Masters Medicine University of California, San Francisco
PhD Neuroscience University of California, San Francisco

Why Is Edward G. Shaw Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Edward G. Shaw's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. (2000) (1365)
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. (2013) (954)
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. (2016) (722)
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. (1994) (695)
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. (2006) (693)
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. (2006) (685)
Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. (2002) (642)
Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. (1993) (621)
Radiation-induced brain injury: A review (2012) (496)
Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. (1989) (410)
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. (2014) (354)
Radiation therapy in the management of low-grade supratentorial astrocytomas. (1989) (315)
Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. (1993) (305)
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. (2012) (296)
Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. (1998) (282)
Oligodendrogliomas: the Mayo Clinic experience. (1992) (280)
Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. (2006) (279)
Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). (1996) (261)
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. (2008) (257)
Papillary craniopharyngioma: a clinicopathological study of 48 cases. (1995) (233)
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. (2003) (232)
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. (2003) (212)
Spinal cord astrocytoma: pathological and treatment considerations. (1995) (190)
Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. (2011) (186)
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. (1997) (182)
A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. (2007) (180)
Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. (2007) (178)
Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients (1993) (175)
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. (2006) (174)
Interim report on the radiosurgical treatment of cerebral arteriovenous malformations. The influence of size, dose, time, and technical factors on obliteration rate. (1995) (173)
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial. (2015) (172)
The results of radiotherapy for ependymomas: the Mayo Clinic experience. (1998) (166)
Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. (2011) (161)
Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. (2009) (156)
Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. (2008) (153)
Managing the cognitive effects of brain tumor radiation therapy (2006) (145)
Mixed oligoastrocytomas: a survival and prognostic factor analysis. (1994) (145)
Choroid plexus papillomas: long-term follow-up results in a surgically treated series. (1988) (145)
Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. (2005) (145)
Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. (1992) (138)
Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. (1990) (137)
Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. (1987) (136)
Analysis of outcome in patients reirradiated for brain metastases. (1996) (136)
Gamma knife for glioma: selection factors and survival. (1996) (128)
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. (2011) (128)
Astrocytomas of the cerebellum: A comparative clinicopathologic study of pilocytic and diffuse astrocytomas (1993) (127)
Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? (1995) (127)
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. (1996) (126)
Results of surgical treatment for growth hormone-secreting pituitary adenomas. (1993) (125)
Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. (1999) (123)
An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. (2003) (107)
The Significance of Atypia and Histologic Malignancy in Pilocytic Astrocytoma of the Cerebellum: A Clinicopathologic and Flow Cytometric Study (1994) (106)
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. (1994) (103)
Prospective clinical trials of intracranial low-grade glioma in adults and children. (2003) (103)
Spinal cord gliomas: A multi-institutional retrospective analysis. (2006) (102)
Radiotherapeutic management of adult intraspinal ependymomas. (1986) (101)
RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. (2003) (100)
Outcome after spinal reirradiation for malignant epidural spinal cord compression (1995) (100)
Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline (2013) (99)
Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. (2006) (98)
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. (2013) (96)
Supratentorial gliomas: a comparative study by grade and histologic type (1997) (96)
Postoperative radiotherapy of supratentorial low-grade gliomas. (1989) (95)
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. (2007) (94)
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement (1997) (93)
Leukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation (1989) (93)
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. (2014) (91)
Radiosurgical treatment of recurrent hemangiopericytomas of the meninges: preliminary results. (1993) (91)
Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC (2014) (83)
Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery (2012) (82)
The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. (2012) (80)
Symptomatic subependymoma: a clinicopathological and flow cytometric study. (1991) (79)
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. (2004) (76)
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma (1998) (76)
Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. (2012) (74)
A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. (2014) (73)
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. (2020) (71)
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. (2004) (69)
Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience. (1990) (69)
Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG. (2014) (68)
The neurocognitive effects of radiation in adult low-grade glioma patients. (2003) (67)
Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery. (2012) (65)
Limited Margins Using Modern Radiotherapy Techniques Does Not Increase Marginal Failure Rate of Glioblastoma (2014) (65)
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. (1994) (63)
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. (2012) (60)
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. (2000) (59)
Stereotactic Radiosurgical Treatment of Cerebral Arteriovenous Malformations (1995) (58)
A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy (2016) (58)
Management of supratentorial low-grade gliomas. (1991) (57)
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. (2015) (56)
Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery (2012) (55)
Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. (2007) (54)
Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: A pilot study (2012) (53)
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood (2012) (50)
Symptom clusters in patients with newly-diagnosed brain tumors. (2007) (49)
Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. (2013) (48)
Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients (2003) (48)
Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? (2014) (47)
The management of radiation-induced brain injury. (2006) (45)
Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. (2014) (45)
Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG) (2008) (45)
The management of patients with primary central nervous system (CNS) germinoma: Current controversies requiring resolution (2008) (44)
Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung. (1993) (44)
Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis. (1992) (42)
A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. (2001) (42)
Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions. (2007) (41)
Consensus statement on stereotactic radiosurgery: quality improvement. (1994) (41)
Low-grade gliomas: to treat or not to treat? A radiation oncologist's viewpoint. (1990) (41)
Malignant tracheoesophageal fistula in patients with esophageal cancer (1993) (39)
Randomized trials of radiation therapy in adult low-grade gliomas. (2001) (39)
Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy. (2006) (39)
Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung. (1989) (39)
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. (2010) (39)
Does dose rate affect efficacy? The outcomes of 256 gamma knife surgery procedures for trigeminal neuralgia and other types of facial pain as they relate to the half-life of cobalt. (2006) (37)
Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis. (1997) (37)
Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer. (1995) (37)
Locally recurrent non-small-cell lung cancer after complete surgical resection. (1992) (36)
Current controversies in the radiotherapeutic management of adult low-grade glioma. (2004) (36)
Initial report of Radiation Therapy Oncology Group (RTOG) 9802: Prospective studies in adult low-grade glioma (LGG). (2006) (35)
A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. (2012) (35)
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. (2013) (34)
An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94–02 (2004) (33)
Brain metastatic lesions. (1994) (32)
Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival. (2006) (32)
Single-Institution Retrospective Series of Gamma Knife Radiosurgery in the Treatment of Multiple Sclerosis-Related Trigeminal Neuralgia: Factors that Predict Efficacy (2013) (31)
Repeat gamma knife radiosurgery for trigeminal neuralgia. (2011) (31)
Topical Review Article: Medulloblastoma: I. Clinical, Diagnostic, and Therapeutic Overview (1992) (31)
Education and Training for Radiation Scientists: Radiation Research Program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12–14, 2003 (2003) (30)
Lessons learned from randomised clinical trials in adult low grade glioma. (2005) (28)
Qualitative longitudinal analysis of symptoms in patients with primary and metastatic brain tumours (2008) (28)
Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population. (2018) (28)
An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94-02. (2004) (27)
The practical management of low-grade primary brain tumors (1999) (26)
Doses to radiation sensitive organs and structures located outside the radiotherapeutic target volume for four treatment situations. (1993) (26)
The results of radiotherapy for brainstem tumors (1998) (26)
Hippocampal dose volume histogram predicts Hopkins Verbal Learning Test scores after brain irradiation (2017) (26)
Medulloblastoma: I. Clinical, diagnostic, and therapeutic overview. (1992) (26)
Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients (2019) (25)
A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy (2008) (24)
Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy. (2002) (24)
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance). (2015) (23)
Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review. (2010) (23)
Radiation oncology in brain tumors: current approaches and clinical trials in progress. (2010) (22)
Stereotactic radiosurgical treatment of cerebral arteriovenous malformations. Gamma Unit Radiosurgery Study Group. (1995) (22)
Chemotherapy plus radiotherapy (CT-RT) versus RT alone for patients with anaplastic oligodendroglioma: Long-term results of the RTOG 9402 phase III study. (2012) (20)
Gamma Knife Radiosurgery in the Treatment of Tumor-Related Facial Pain (2012) (19)
Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosis. (2011) (19)
Final report from intergroup NCCTG 86-72-51 (Alliance): a phase 3 randomized clinical trial of high dose versus low dose radiation for adult low-grade glioma. (2020) (19)
Three-dimensional conformal radiation treatment planning and delivery for low- and intermediate-grade gliomas. (2001) (19)
Sarcomas of calvarial bones (1994) (18)
Standard whole brain radiation therapy (WBRT) with supplemental oxygen (O2), with or without RSR13 (efaproxiral)in patients with brain metastases: Results of the randomized REACH (RT-009) study. (2004) (18)
Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non‐small cell lung carcinoma (1993) (17)
Prophylactic cranial irradiation in limited‐stage small cell lung cancer (1995) (17)
Mild cognitive impairment in long-term brain tumor survivors following brain irradiation (2018) (16)
Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study (2019) (16)
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer. (1996) (16)
The low-grade glioma debate: evidence defending the position of early radiation therapy. (1995) (16)
A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). (2008) (16)
Update of radiation therapy oncology group (RTOG) protocol 9005: Single dose radiosurgical treatment of recurrent brain tumors (1998) (15)
Treatment toxicities in long-term survivors of limited small cell lung cancer. (1988) (15)
Retrospective analysis of imaging techniques for treatment planning and monitoring of obliteration for gamma knife treatment of cerebral arteriovenous malformation. (2012) (15)
Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0 T versus 1.5 T MRI‐based treatment planning: Have we finally optimised detection of occult brain metastases? (2012) (15)
Staged Gamma Knife Radiosurgery for Large Cerebral Arteriovenous Malformations (2011) (15)
Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (15)
CT‐only planning for Gamma Knife radiosurgery in the treatment of trigeminal neuralgia: Methodology and outcomes from a single institution (2012) (14)
Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a north central cancer treatment group (NCCTG) prospective study (2003) (14)
A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia. (2012) (14)
A Phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM) (2004) (13)
Nothing ventured, nothing gained: Treatment of glioblastoma multiforme in the elderly. (2004) (13)
Pre-irradiation evaluation and management of brain metastases. American College of Radiology. ACR Appropriateness Criteria. (2000) (12)
Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors. (2013) (12)
Principles and Practice of Radiation Oncology (1992) (12)
A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas (2012) (11)
Role of radiation therapy in the management of low‐grade gliomas (1992) (11)
Radiosurgical management of trigeminal neuralgia. (2013) (11)
Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases (2006) (11)
Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer. (2015) (11)
AT-13R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE (2014) (11)
Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial (2018) (10)
Follow-up and retreatment of brain metastasis. American College of Radiology. ACR Appropriateness Criteria. (2000) (10)
Phase II double-blind placebo-controlled study of armodafinil for brain radiation induced fatigue. (2013) (10)
Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer (1995) (9)
A multi-institimonal experience with stereotactic radksurgery for solitary brain metastases (1993) (9)
Edema following Gamma-Knife® radiosurgery for intracranial meningiomas (2002) (9)
National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors. (2017) (8)
Genetic analysis of second primary lung cancers in patients surviving small cell lung cancer. (1996) (8)
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation therapy oncology group trial 9402. (2009) (8)
Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105. (2018) (8)
Role of radiation therapy in the management of lung cancer. (1993) (8)
A Randomized Trial of Chemotherapy Plus Radiotherapy (RT) versus RT alone for Anaplastic Oligodendroglioma (RTOG 9402): The Perspective of Longer Follow-up (2008) (8)
A randomized double-blind placebo-controlled study of oral coenzyme Q10 to relieve self-reported cancer-treatment-related fatigue in newly diagnosed breast cancer patients. (2010) (8)
Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma. (1994) (7)
Updated predictive analysis of the WHO-defined molecular subgroups of low-grade gliomas within the high-risk treatment arms of NRG Oncology/RTOG 9802. (2019) (7)
Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106. (2015) (7)
Central Nervous System Tumors (2006) (7)
Postoperative radiation for supratentorial low grade gliomas (1987) (7)
Low-grade glioma: current management and controversies. (2003) (7)
Stress and depression in head and neck cancer patients by primary surgery versus primary radiotherapy treatment modality. (2010) (7)
ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG). (2015) (6)
Matching intraoperative electron-beam fields: dosimetric and clinical considerations. (1986) (6)
9 Radiosurgical treatment of previously irradiated primary brain tumors and brain metastasis: Final report of radiation therapy oncology group (RTOG) protocol 90-05 (1995) (6)
Spinal cord localization in the treatment of lung cancer: use of radiographic landmarks. (1998) (6)
The Evolving Role of Biological Imaging in Stereotactic Radiosurgery (2003) (6)
NCCTG 94–72-53: Diagnostic and prognostic significance of 1p and 19q deletions in patients (pts) with low-grade oligodendroglioma and astrocytoma (2005) (6)
Cognition and Cancer: Biological bases of radiation injury to the brain (2008) (6)
Symptom clusters in newly-diagnosed brain tumor patients. (2006) (6)
Central Nervous System Emergencies (2006) (5)
Supratentorial low-grade glioma: is there a role for radiation therapy? (1996) (5)
Radiotherapeutic management of multiple brain metastases: "3000 in 10" whole brain radiation is no longer a "no brainer". (1999) (5)
IT-23INDUCTION OF ROBUST TYPE-1 CD8+ T-CELL RESPONSES IN WHO GRADE II LOW-GRADE GLIOMA PATIENTS RECEIVING PEPTIDE-BASED VACCINES IN COMBINATION WITH POLY-ICLC (2014) (5)
A Phase III, Double Blind, Placebo-Controlled, Prospective Randomized Trial on the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Lung Cancer and Head and Neck Cancer Patients Receiving Curative Radiation Therapy (2005) (5)
Treatment of Atypical Meningiomas with Gamma Knife Radiosurgery: The Role of Conformality Index and Margin Dose (2009) (5)
Radiation treatment of growth hormone secreting pituitary adenomas (1991) (5)
Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT + PCV in High-risk Low-grade Gliomas (2019) (5)
101 The impact of surgical adjuvant thoracic radiation therapy for non-small cell lung cancer patients with mediastinal nodal involvement (1996) (5)
ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS (2017) (5)
Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG) (2014) (5)
Solitary brain metastasis. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
Radiation-induced adult medulloblastoma: a two-case report and review of the literature (2011) (4)
Determination of a Clinical Value for the Repair Half-Time (T1/2) of the Trigeminal Nerve Based on Outcome Data from Gamma Knife Radiosurgery for Facial Pain (2007) (4)
Impact of radiosurgical management of geriatric patients with brain metastases: Clinical and quality of life outcomes. (2013) (4)
A Phase III, Double Blind, Placebo-Controlled Prospective Randomized Clinical Trial of Effect of d-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy (2005) (4)
Preliminary efficacy of an enhanced quitline smoking cessation intervention for cancer patients. (2015) (4)
Interim results of a Phase II study of resection and GliaSite brachytherapy for a single brain metastasis (2004) (4)
Some like it hot...and others not! (2009) (4)
Shape factor analysis of progressive rat hepatoma images. (2008) (4)
In search of better prognostic indicators for patients with oligodendrogliomas. (1996) (3)
Safety profile of efaproxiral (RSR13), a novel radiation sensitizer, in patients undergoing radiation therapy. (2004) (3)
Abstracts of the 110 th meeting of the British Neuropathological Society (2008) (3)
A Phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on weight (wt), lean body mass (LBM) and quality of life (QOL) in solid tumor patients (pts) receiving chemotherapy (chemo). (2006) (3)
Abstract LB-135: A pilot study of peptide-based vaccines in combination with poly ICLC in patients with WHO grade 2 low-grade glioma (2012) (3)
Normal Tissue Complication Modeling of the Brain: Dose-volume Histogram Analysis of Neurocognitive Outcomes of Two CCOP Trials (2011) (3)
Bioanatomic IMRT treatment planning with dose function histograms (2002) (3)
The effects of radiation on cognative function in patients with low-grade glioma (2001) (3)
IMMUNOTHERAPY/BIOLOGICAL THERAPIES (2013) (3)
Phase III randomized, double-blind, placebo-controlled trial of soy protein and venlafaxine for treatment of hot flashes in men with prostate cancer. (2011) (2)
Pharmacokinetics (PK) of RSR13 (efaproxiral) predict survival in patients with brain metastases randomized to receive whole brain radiation therapy (WBRT) with or without RSR13 (REACH RT-009). (2004) (2)
Patterns of Failure in Patients Receiving Gamma Knife Radiosurgery for Breast Carcinoma to the Brain (2011) (2)
2018 Eningiomas: Outcome, and analysis of prognostic factors of primarily resected tumors (1996) (2)
Meningiomas: Outcomes and Analysis of Prognostic Factors of Primarily Resected Tumors (1996) (2)
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung. (1996) (2)
Does L-arginine/Korean ginseng/gingko biloba/damiana-based supplement improve the sexual function and quality of life of female cancer survivors: A randomized trial. (2011) (2)
A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck Cancer (2017) (2)
2179 A phase Ib study to evaluate repeated daily intravenous doses of RSR 13 administered to cancer patients receiving concurrent radiation therapy (1997) (2)
ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402 (2019) (2)
Phase II study of ginkgo biloba in irradiated brain tumor survivors: Effects on quality of life (QOL), mood, and cognitive function. (2010) (2)
Pilot studies of the north central cancer treatment group (NCCTG) utilizing accelerated hyperfractionated thoracic radiation therapy (AHTRT) in unresectable stage IIIA/B non-small cell lung cancer (NSCLC) (1994) (2)
2060 : Pseudo-Progression Based on MRI Changes Following Radiation Therapy for Pilocytic Astrocytoma (2006) (2)
18 Conventionally Fractionated Stereotactic Radiotherapy for Vestibular Schwannoma: A Single Institutional Long-term Outcomes (2010) (2)
Symptom clusters in irradiated brain tumor survivors. (2006) (2)
Prognostic Factors for Survival in Adult Patients with Recurrent Glioma Enrolled on New Approaches to Brain Tumor Therapy “NABTT” CNS Consortium Phase I and II Clinical Trials (2014) (1)
A phase III randomized, double-blind, placebo controlled trial of North American (NA) ginseng (Panax quinquefolium) extract (CVT-E002) in patients with chronic lymphocytic leukemia: Effect on respiratory infection and antibiotic use. (2010) (1)
CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES (2012) (1)
Salvage Radiosurgery for Patients with Small Cell Lung Cancer after Previous Whole Brain Radiations (2010) (1)
ASTROCYTIC TUMORS OF THE SPINAL CORD (1993) (1)
Presidential symposium on low-grade glioma. (2003) (1)
Recruitment and retention in the Wake Forest University CCOP Research Base. (2010) (1)
Mild cognitive impairment (MCI) in chemotherapy-treated breast cancer survivors. (2015) (1)
SYMPTOM MANAGEMENT/QUALITY OF LIFE (2013) (1)
Outcomes for Gamma Knife Radiosurgery for Brainstem Metastases (2011) (1)
Predictors of Durability of Response for Stereotactic Radiosurgery in the Treatment of Trigeminal Neuralgia (2012) (1)
Chapter 26 – Low-Grade Gliomas (2016) (1)
Relationship between Radiosurgery Conformity Indices and Acoustic Neuroma Tumor Volume (2010) (1)
Resident essay award: Matching intraoperative electron-beam fields: Dosimetric and clinical considerations (1988) (1)
Radiation therapy (RT) alone vs intensive procarbazine-CCNU-vincristine (I-PCV) chemotherapy followed by radiation therapy for anaplastic oligodendroglioma (AO) and mixed oligo-astrocytoma (MOA): Results of radiation therapy oncology group (RTOG) - intergroup protocol 94–02 (2004) (1)
Feasibility of using memantine in smoking cessation among cancer survivors. (2015) (1)
Diffuse gliomas of the cerebellum: A clinicopathologic study of 30 cases (1990) (1)
RSR13 plus cranial radiation therapy improves survival in patients with brain metastases compared to the RTOG recursive partitioning analysis brain metastases database: Update of a phase II trial (2000) (1)
Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs). (2016) (1)
Tumor Histology Predicts Patterns of Failure and Survival in Patients with Lung Cancer Treated with Gamma Knife Radiosurgery (2011) (1)
Phase II study of preirradiation chemotherapy for CNS germ cell malignancies: Long-term complications. (2010) (1)
Analysis of Toxicity in Patients with Collagen Vascular Diseases or Multiple Sclerosis Treated with Gamma Knife Radiosurgery for Intracranial Tumors (2010) (1)
Endobronchial Irradiation for Airway Obstruction: How Do The Techniques Rate? (1994) (1)
Phase I study of gadolinium texaphyrin in newly diagnosed glioblastoma (2007) (1)
Erratum to: Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? (2014) (0)
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity Research Base Name: Comprehensive Cancer Center of Wake Forest CCOP Research Base (CCCWF CCOP RB) (2011) (0)
Abstract 1615: C-Reactive protein and radiotherapy-induced skin toxicity in breast cancer (2017) (0)
IDH Status Predicts Benefit From PCV With Radiation Therapy in Anaplastic Oligodendroglioma (RTOG 9402) (2012) (0)
ASTRO refresher course descriptionManagement of supratentorial low-grade gliomas (1993) (0)
103 A phase I study of the safety and performance of the gliasite radiotherapy system for brachytherapy treatment of resected malignant glioma cavities (2000) (0)
1029 A phase II trial of the radiosensitizer: Etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG PROTOCOL #95-02) (1999) (0)
Late Breast Toxicity Rates in a Prospective Evaluation of Radiation Therapy (RT) in a Multiracial/Ethnic Population of Breast Cancer (BC) Patients (2015) (0)
Comparing three validated methods of patient self-reported fatigue in a prospective randomized clinical trial. (2012) (0)
CLIN-NEURO-COGNITIVE (2012) (0)
Diagnostic and prognostic significance of a t(1;19)(q10;p10) in patients (pts) with low-grade oligodendroglioma and astrocytoma: NCCTG 94-72-53. (2016) (0)
Meningiomas: Outcomes and Analysis of Prognostic Factors of Primarily Resected Tumors Paper #745 (1996) (0)
NCOG-24. WAKE FOREST NCORP RESEARCH BASE FEASIBILITY STUDY OF RAMIPRIL FOR PREVENTING COGNITIVE DECLINE IN GLIOBLASTOMA PATIENTS RECEIVING BRAIN RADIOTHERAPY (WF-1801) (2020) (0)
Decreased CTV Margin Size Does Not Affect Patterns of Failure for Glioblastoma Treated with Concurrent Radiotherapy and Temozolomide (2011) (0)
A phase II pilot of St. John's wort for the treatment of hot flushes in women with a history of breast cancer. (2011) (0)
Title : Development of a flexible and specific gene delivery system for production of murine tumor models (2000) (0)
A Phase I Dose Escalation Study of IMRT Field-in-field Boost for Newly Diagnosed Glioblastoma Multiforme (GBM) (2008) (0)
The treatment of supratentorial low-grade gliomas (1990) (0)
Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical Trial. (2022) (0)
Adjuvant chemotherapy (AC) use and toxicity in oestrogen receptor positive (ER+), lymph node negative (LN-), Her-2 negative (H2-) breast cancer (<75yrs) in Northern Ireland (2016) (0)
Adverse Toxicity After Stereotactic Radiosurgery for Treatment of Meningiomas (2013) (0)
Correlation of cognitive symptoms with cognitive performance among brain cancer patients after radiation therapy. (2010) (0)
Abstract 1900: Radiotherapy-induced early adverse skin reactions: Comparative analysis of clinician- and patient-reported outcomes in a multi-racial/ethnic breast cancer population (WF-97609) (2023) (0)
10 Prognostic factors associated with radiosurgery for malignant glioma: Results of a multi institutional Gamma Knife study (1995) (0)
TRAIT (Treatment-Related Alterations in Thinking): A Prospective Longitudinal Study Assessing Mild Cognitive Impairment in Irradiated Brain Tumor Patients (2018) (0)
Predictive Factors for Distant Brain Failure After Primary Radiosurgical Management of Brain Metastases (2012) (0)
Tumor-related Facial Pain: Response to Gamma Knife Radiosurgery (2008) (0)
Limited-stage small cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy (1993) (0)
L-arginine–Based Nutritional Supplement Did Not Improve Erectile Function or Quality of Life in Prostate Cancer Survivors Previously Treated With Radiation Therapy: Results of CCOP Research Base Protocol 98110 – A Randomized Phase 2 Dose Finding Study (2014) (0)
Prognostic factors for survival in patients with brain metastases enrolled on a worldwide phase 3 randomized trial of 538 patients (study RSR13 RT–009) (2004) (0)
WSSF Society News (2014) (0)
Self-reported compliance compared to biomarker levels of vitamin E in breast cancer patients participating in a CoQ10 clinical trial. (2010) (0)
Intracranial low-grade glioma (LGG): Influence of various proliferation indices and other prognostic factors on outcome (1998) (0)
The effect of treatment selection on outcome in spinal cord gliomas (2000) (0)
Mike Robbins 1954–2013 (2013) (0)
Real-world use of anti-PD-1 checkpoint inhibitors in the management of non-small cell lung cancer: experience from a large UK teaching hospital (2018) (0)
Low Grade Gliomas: Demographic, Tumor and Treatment Factors Associated With Survival (2007) (0)
Predictive Variables for Successful Treatment of Trigeminal Neuralgia with Radiosurgery (2010) (0)
The Outcome of Gamma Knife Radiosurgery for Facial Pain Varies by Pre-treatment Burchiel Classification Pain Type: Results From 256 Gamma Knife Radiosurgery Procedures for Facial Pain (2005) (0)
Modern Radiation Oncology: Classic Literature and Current Management (1985) (0)
Quality of life (QOL) and cognitive status among irradiated brain tumor survivors treated with donepezil or placebo. (2013) (0)
Dorsal Root Entry Zone Dose Predicts Efficacy and Toxicity for Patients Receiving a Second Radiosurgical Treatment for Recurrent Trigeminal Neuralgia (2009) (0)
Radiation Therapy of Pituitary Tumors (2001) (0)
ADAMANTINOMATOUS AND PAPILLARY CRANIOPHARYNGIOMA: A CUNICOPATHOLOGIC ANALYSIS (1993) (0)
Phase II randomized placebo-controlled double-blind chemoprevention trial of fruit/vegetable concentrates on intermediate biomarkers in head/neck cancer. (2010) (0)
Contents Vol. 89, 2011 (2011) (0)
Adjuvant Radiosurgery after Resection of a Brain Metastasis Allows for the Delay or Elimination of Whole Brain Radiotherapy (2009) (0)
Prophylactic megestrol acetate (MEGACE) in head & neck and lung cancer patients receiving radiation therapy: Effect on weight, quality of life (QOL), and toxicity in a phase III placebo controlled trial (2000) (0)
Minority accrual on a prospective study targeting a diverse U.S. breast cancer population: An analysis of Wake Forest CCOP research base protocol 97609. (2013) (0)
A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813. (2016) (0)
Response to Choi's "Controversies in the role of postoperative radiotherapy in stages II and IIIA resected non-small cell lung carcinoma". (1992) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
97 Phase III comparison of standardly fractionated thoracic radiotherapy to accelerated hyperfractionated thoracic radiotherapy with or without chemotherapy for patients with locally advanced non-small cell lung cancer (Stage IIIA/B) (1996) (0)
Phase I study of the gliasite radiotherapy system for brachytheray of brain tumor resection cavities (2000) (0)
Optic pathway glioma: a clinicopathologic study of prognostic indicators and postoperative radiation (2000) (0)
Michael E. Robbins, Ph.D. 1954–2012 (2013) (0)
Effects o f R adiotherapy o n C ognitive F unction i n P atients With L ow-Grade G lioma M easured b y t he F olstein Mini-Mental S tate E xamination (2003) (0)
A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG) (2007) (0)
133 Analysis of outcome in patients reirradiateii for brain metastases (1995) (0)
Abstracts of the 6th Canadian Neuro-Oncology Meeting May 18–21, 1994 Lake Louise, Alberta (1994) (0)
Clinical Radiation Oncology: Indications, Techniques, and Results (1989) (0)
The Effect of Dose Rate on the Outcomes of 256 Gamma Knife Radiosurgery Procedures for Facial Pain (2005) (0)
Oxidative DNA Damage in Radiation Therapy Related Early Adverse Skin Reactions in Breast Cancer (2015) (0)
Quality of life (QOL) and cognitive performance among irradiated brain cancer patients. (2010) (0)
Review of variation between clinical and pathological TNM staging in real-life cases of non-small cell lung cancer (2020) (0)
Low-versus high-energy photon beams in radiotherapy for lung cancer. (1993) (0)
15 Radiation Therapy of Pituitary Tumors Including Stereotactic Radiosurgery (2001) (0)
Chapter 24 – Low-Grade Gliomas (2012) (0)
CTNI-16. NRG-RTOG 9802 OBSERVATION ARM - LONG TERM RESULT (2022) (0)
Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study (2019) (0)
The gliasite radiation therapy system (RTS): a novel approach to brain brachytherapy for recurrent malignant glioma (2001) (0)
Incidence of Mild Cognitive Impairment in Irradiated Brain Tumor Survivors (2014) (0)
Malignant tracheosophageal fistula in patients with esophageal cancer (1992) (0)
MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS (2016) (0)
Cognition and Cancer: Pharmacological interventions for the treatment of radiation-induced brain injury (2008) (0)
5.29 Potential of AFX-2, a Unique, Polysaccharide-Based Toll-like Receptor Agonist, in Patients With Chronic Lymphocytic Leukemia (2011) (0)
Comparison of Clinical Outcomes for Single Focus and Multifocal Glioblastoma (2012) (0)
BENEFICIAL OUTCOMES AFTER PCV PLUS RT IN OLIGODENDROGLIAL TUMORS ARE ASSOCIATED WITH DETECTION OR RISK OF AN IDH MUTATION. (2014) (0)
Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol (2018) (0)
A patients’ satisfaction survey on speed of the Leicester optimal lung cancer pathway (2020) (0)
Editor-in-chief Advisory Board Editorial Board Select Review in Neuro-oncology Title: Intra-arterial Cereport (rmp-7) and Carboplatin: a Dose Escalation Study for Recurrent Malignant Title: C-myc Oncogene Family Expression in Glioblastoma and Survival Medical Oncology Title: Prophylactic Cranial Irr (2000) (0)
Response at 3–months after whole brain radiation therapy predicts survival in brain metastases patients (2004) (0)
Quality of life and cognitive dysfunction in breast cancer survivors on a feasibility study of donepezil versus placebo. (2014) (0)
A prospective evaluation of radiotherapy (RT) related skin reactions in a multi-racial/ethnic population of women with newly diagnosed breast cancer (BC). (2015) (0)
ACTR-07. LONG-TERM OUTCOMES FROM INTERGROUP NCCTG 86-72-51 (ALLIANCE): FINAL REPORT OF A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF HIGH DOSE VERSUS LOW DOSE RADIATION IN ADULT SUPRATENTORIAL LOW-GRADE GLIOMA (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Edward G. Shaw?

Edward G. Shaw is affiliated with the following schools:

University of California, Irvine
MD Anderson Cancer Center
Wake Forest University
Johns Hopkins University

Edward G. Shaw's Academic­Influence.com Rankings

Edward G. Shaw's Degrees

Why Is Edward G. Shaw Influential?

Edward G. Shaw's Published Works

Published Works

What Schools Are Affiliated With Edward G. Shaw?

Edward G. Shaw's AcademicInfluence.com Rankings